# VTGN (Vistagen Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Vistagen Therapeutics, Inc. reported $2.38M in revenue and a net loss of $58.94M for the trailing twelve months ended September 30, 2026 (down 46.5% year over year), with a -2541.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/VTGN
- Markdown: https://convexityos.com/fundamentals/VTGN.md
- SEC CIK: 0001411685
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001411685&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.38M | -46.5% YoY |
| Operating Income | TTM | -$60.55M | -2541.9% margin |
| Net Income | TTM | -$58.94M | -2474.5% net margin |
| Diluted EPS | TTM | -$1.33 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $20.03M | Total debt: $610K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.27M | $486K | $1.06M | -$227K | $1.11M | $1.09M | $0 | -- | $0 | $1.25M |
| Research & Development | $54.97M | $39.38M | $20.02M | $44.38M | $35.41M | $11.93M | $13.37M | $17.10M | $7.76M | $5.20M |
| Total Operating Expenses | $73.39M | $56.46M | $34.09M | $59.04M | $48.89M | $19.02M | $20.80M | $24.56M | $14.20M | $11.50M |
| **Operating Income** | -$72.13M | -$55.97M | -$33.02M | -$59.27M | -$47.78M | -$17.93M | -$20.80M | -$24.56M | -$14.20M | -$10.25M |
| **EBITDA** | -$71.93M | -$55.82M | -$32.89M | -$59.14M | -$47.63M | -$17.82M | -$20.70M | -$24.47M | -$14.12M | -$10.19M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $8.0K | $8.9K | $4.6K |
| Income Before Tax | -$69.68M | -$51.41M | -$29.36M | -$59.24M | -$47.76M | -$17.93M | -$20.77M | -$24.59M | -$14.34M | -$10.25M |
| Income Tax Expense | $7.0K | $7.0K | $4.0K | $6.0K | $3.4K | $2.6K | $2.6K | $2.6K | $2.4K | $2.4K |
| **Net Income** | -$69.69M | -$51.42M | -$29.36M | -$59.25M | -$47.76M | -$17.93M | -$20.77M | -$24.59M | -$14.35M | -$10.26M |
| Basic EPS | -$1.83 | -$1.67 | -$1.52 | -$8.51 | -$7.38 | -$14.71 | -$15.02 | -$27.03 | -$33.63 | -$46.25 |
| **Diluted EPS** | -$1.83 | -$1.67 | -$1.52 | -$8.51 | -- | -$14.71 | -$15.02 | -$27.03 | -$33.63 | -$46.25 |
| Basic Shares Outstanding | 38.1M | 30.9M | 19.4M | 7.0M | 6.6M | 2.9M | 1.5M | 951.1K | 462.5K | 250.8K |
| Diluted Shares Outstanding | 38.1M | 30.9M | 19.4M | 7.0M | -- | 2.9M | 1.5M | 951.1K | 462.5K | 250.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $138K | $1.48M | $465K | $303K | $258K | $244K | -$15K | $234K |
| Research & Development | $6.55M | $10.91M | $13.06M | $14.22M | $15.91M | $11.68M | $10.21M | $11.30M |
| Total Operating Expenses | $11.07M | $14.82M | $17.18M | $19.85M | $20.31M | $16.05M | $14.48M | $15.35M |
| **Operating Income** | -$10.94M | -$13.35M | -$16.72M | -$19.55M | -$20.05M | -$15.80M | -$14.49M | -$15.12M |
| **EBITDA** | -$10.89M | -$13.30M | -$16.66M | -$19.49M | -$20.00M | -$15.76M | -$14.46M | -$15.08M |
| Income Before Tax | -$10.74M | -$13.03M | -$16.27M | -$18.90M | -$19.42M | -$15.10M | -$13.63M | -$14.09M |
| Income Tax Expense | $0 | $0 | $7.0K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$10.74M | -$13.03M | -$16.27M | -$18.90M | -$19.42M | -$15.10M | -$13.63M | -$14.09M |
| Basic EPS | -$0.24 | -$0.30 | -- | -$0.45 | -$0.54 | -$0.47 | -- | -$0.46 |
| **Diluted EPS** | -$0.24 | -$0.30 | -- | -$0.45 | -$0.54 | -$0.47 | -- | -$0.46 |
| Basic Shares Outstanding | 44.4M | 43.0M | -- | 42.2M | 35.7M | 31.9M | -- | 30.7M |
| Diluted Shares Outstanding | 44.4M | 43.0M | -- | 42.2M | 35.7M | 31.9M | -- | 30.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.79M | $67.13M | $119.2M | $16.64M | $68.14M | $103.1M | $1.36M | $13.10M | $10.38M | $2.92M |
| Short-Term Investments | $14.61M | $13.35M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $45.40M | $80.50M | $119.2M | $16.64M | $68.14M | $103.1M | $1.36M | $13.10M | $10.38M | $2.92M |
| **Total Current Assets** | $46.94M | $82.08M | $120.7M | $17.51M | $71.00M | $104.1M | $1.58M | $13.63M | $11.02M | $3.38M |
| Property, Plant & Equipment, Net | $427K | $476K | $435K | $507K | $414K | $367K | $210K | $313K | $207K | $286K |
| Other Non-Current Assets | $393K | $454K | $726K | -- | -- | -- | $48K | $48K | $48K | $48K |
| **Total Non-Current Assets** | $1.62M | $2.27M | $2.98M | $3.58M | $3.65M | $4.16M | $4.19M | $383K | $255K | $334K |
| **Total Assets** | $48.56M | $84.34M | $123.7M | $21.09M | $74.64M | $108.3M | $5.77M | $14.01M | $11.28M | $3.71M |
| Accounts Payable | $1.53M | $653K | $1.55M | $2.47M | $2.76M | $838K | $1.84M | $1.05M | $1.20M | $867K |
| Deferred Revenue (Current) | $1.71M | $2.59M | $791K | $714K | $1.24M | $1.42M | $0 | -- | -- | -- |
| **Total Current Liabilities** | $12.79M | $12.61M | $5.12M | $4.57M | $5.77M | $4.19M | $27.71M | $2.80M | $1.46M | $1.37M |
| Deferred Revenue (Non-Current) | $0 | $391K | $2.67M | $2.31M | $1.56M | $2.49M | $0 | -- | -- | -- |
| **Total Non-Current Liabilities** | $249K | $1.34M | $4.24M | $4.44M | $4.16M | $12.11M | $8.73M | $4.14M | $2.90M | $1.73M |
| **Total Liabilities** | $13.04M | $13.95M | $9.37M | $9.01M | $9.93M | $16.30M | $11.50M | $6.94M | $4.36M | $3.10M |
| **Total Debt (incl. Leases)** | $948K | $1.51M | $2.12M | $2.61M | $3.04M | $3.72M | $4.04M | $9.3K | -- | -- |
| Common Stock | $40K | $29K | $27K | $7.0K | $6.9K | $181K | $49K | $43K | $23K | $9.0K |
| Retained Earnings | -$477.3M | -$407.6M | -$356.2M | -$326.9M | -$267.6M | -$219.8M | -$201.9M | -$181.1M | -$156.5M | -$142.0M |
| Accumulated Other Comp. Income | -$2.0K | $5.0K | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $35.52M | $70.39M | $114.3M | $12.08M | $64.72M | $91.98M | -$5.73M | $7.08M | $6.92M | $616K |
| Total Equity | $35.52M | $70.39M | $114.3M | $12.08M | $64.72M | $91.98M | -$5.73M | $7.08M | $6.92M | $616K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.89M | $16.99M | $30.79M | $47.37M | $62.79M | $48.98M | $67.13M | $74.72M |
| Short-Term Investments | $9.14M | $14.74M | $14.61M | $14.40M | $14.39M | $14.20M | $13.35M | $13.85M |
| **Cash & Short-Term Investments** | $20.00M | $31.70M | $45.40M | $61.80M | $77.20M | $63.20M | $80.50M | $88.60M |
| **Total Current Assets** | $22.29M | $34.31M | $46.94M | $63.24M | $78.93M | $66.72M | $82.08M | $89.94M |
| Property, Plant & Equipment, Net | $325K | $375K | $427K | $480K | $516K | $530K | $476K | $428K |
| Other Non-Current Assets | $289K | $392K | $393K | $392K | $405K | $472K | $454K | $477K |
| **Total Non-Current Assets** | $1.13M | $1.43M | $1.62M | $1.81M | $2.00M | $2.21M | $2.27M | $2.37M |
| **Total Assets** | $23.42M | $35.74M | $48.56M | $65.06M | $80.93M | $68.92M | $84.34M | $92.31M |
| Accounts Payable | $1.08M | $1.00M | $1.53M | $1.28M | $1.83M | $486K | $653K | $1.04M |
| Deferred Revenue (Current) | $96K | $234K | $1.71M | $2.00M | $2.14M | $2.51M | $2.59M | $2.51M |
| **Total Current Liabilities** | $8.43M | $11.19M | $12.79M | $13.53M | $13.64M | $11.15M | $12.61M | $9.62M |
| Deferred Revenue (Non-Current) | $0 | $0 | $0 | $176K | $336K | $221K | $391K | $454K |
| **Total Non-Current Liabilities** | $0 | $63K | $249K | $607K | $946K | $1.00M | $1.34M | $1.56M |
| **Total Liabilities** | $8.43M | $11.26M | $13.04M | $14.14M | $14.59M | $12.16M | $13.95M | $11.19M |
| **Total Debt (incl. Leases)** | $610K | $783K | $948K | $1.05M | $1.21M | $1.42M | $1.51M | $1.71M |
| Common Stock | $46K | $44K | $40K | $40K | $39K | $29K | $29K | $28K |
| Retained Earnings | -$501.1M | -$490.3M | -$477.3M | -$461.0M | -$442.1M | -$422.7M | -$407.6M | -$394.0M |
| Accumulated Other Comp. Income | -$11K | -$7.0K | -$2.0K | $13K | $14K | $1.0K | $5.0K | $11K |
| **Total Stockholders' Equity** | $14.99M | $24.48M | $35.52M | $50.92M | $66.34M | $56.77M | $70.39M | $81.12M |
| Total Equity | $14.99M | $24.48M | $35.52M | $50.92M | $66.34M | $56.77M | $70.39M | $81.12M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$69.69M | -$51.42M | -$29.36M | -$59.25M | -$47.76M | -$17.93M | -$20.77M | -$24.59M | -$14.35M | -$10.26M |
| Depreciation & Amortization | $199K | $150K | $127K | $130K | $154K | $118K | $103K | $91K | $81K | $55K |
| Stock-Based Compensation | $4.00M | $4.32M | $2.18M | $3.34M | $3.48M | $2.31M | $3.82M | $3.44M | $2.34M | $851K |
| **Operating Cash Flow** | -$66.44M | -$42.10M | -$25.81M | -$49.72M | -$45.26M | -$12.07M | -$15.76M | -$14.53M | -$9.06M | -$7.26M |
| Capital Expenditure | -- | -- | $0 | -$528K | -$200K | -$275K | $0 | -$174K | -$1.6K | -$239K |
| **Free Cash Flow** | -- | -- | -$25.81M | -$50.24M | -$45.46M | -$12.35M | -$15.76M | -$14.70M | -$9.06M | -$7.50M |
| Purchases of Investments | -$22.30M | -$24.98M | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$877K | -$13.15M | -$61K | -$740K | -$200K | -$275K | $0 | -$174K | -$1.6K | -$239K |
| Common Stock Issued | $8.0K | $0 | $93.45M | $0 | -- | $12.96M | $3.35M | $17.04M | $16.72M | $9.90M |
| **Financing Cash Flow** | $30.97M | $3.21M | $128.4M | -$1.04M | $10.48M | $114.1M | $4.01M | $17.42M | $16.52M | $9.99M |
| **Net Change in Cash** | -$36.34M | -$52.03M | $102.5M | -$51.50M | -$34.97M | $101.8M | -$11.75M | $2.72M | $7.46M | $2.49M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.74M | -$13.03M | -$16.27M | -$18.90M | -$19.42M | -$15.10M | -$13.63M | -$14.09M |
| Depreciation & Amortization | $50K | $52K | $52K | $54K | $53K | $40K | $40K | $39K |
| Stock-Based Compensation | $907K | $991K | $889K | $1.10M | $1.10M | $916K | $963K | $1.08M |
| **Operating Cash Flow** | -$12.16M | -$14.71M | -$16.20M | -$17.63M | -$13.76M | -$18.85M | -$10.06M | -$10.28M |
| Purchases of Investments | -$962K | -$5.60M | -$5.67M | -$5.87M | -$2.03M | -$8.72M | -$3.92M | -$2.42M |
| **Investing Cash Flow** | $5.71M | $0 | -$99K | $104K | -$94K | -$788K | $527K | -$422K |
| Common Stock Issued | $351K | $928K | -- | $2.31M | $27.93M | $397K | -- | $1.06M |
| **Financing Cash Flow** | $351K | $909K | -$283K | $2.11M | $27.65M | $1.49M | $1.95M | $1.17M |
| **Net Change in Cash** | -$6.10M | -$13.80M | -$16.58M | -$15.41M | $13.80M | -$18.15M | -$7.58M | -$9.53M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -5683.7% | -11517.1% | -3103.5% | -- | -4308.3% | -1646.1% | -- | -- | -- | -819.9% |
| **Net Profit Margin** | -5491.3% | -10579.8% | -2759.6% | -- | -4306.8% | -1646.1% | -- | -- | -- | -820.4% |
| Return on Equity (ROE) | -196.2% | -73.0% | -25.7% | -490.5% | -73.8% | -19.5% | -- | -347.5% | -207.4% | -1665.4% |
| Return on Assets (ROA) | -143.5% | -61.0% | -23.7% | -280.9% | -64.0% | -16.6% | -359.9% | -175.5% | -127.2% | -276.3% |
| Current Ratio | 3.67x | 6.51x | 23.55x | 3.83x | 12.32x | 24.85x | 0.06x | 4.87x | 7.56x | 2.47x |
| Quick Ratio | 3.55x | 6.38x | 23.27x | 3.64x | 11.82x | 24.61x | 0.05x | 4.68x | 7.12x | 2.14x |
| Debt to Equity | 0.03x | 0.02x | 0.02x | 0.22x | 0.05x | 0.04x | -- | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +161.1% | -54.3% | -- | -120.5% | +1.8% | -- | -- | -- | -100.0% | -- |
| 5Y Revenue / Share Growth | -91.2% | -- | -- | -- | -96.6% | -- | -- | -- | -100.0% | -- |
| 10Y Revenue / Share Growth | -- | -- | -- | -100.6% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -2541.9% | -2784.3% | -5678.7% | -8847.8% | -9080.7% | -9233.1% | -11517.1% | -7569.8% |
| **Net Profit Margin** | -2474.5% | -2702.6% | -5487.0% | -8486.8% | -8631.9% | -8634.7% | -10579.8% | -6777.1% |
| Return on Equity (ROE) | -393.2% | -276.2% | -196.2% | -131.7% | -93.8% | -98.3% | -73.0% | -58.3% |
| Return on Assets (ROA) | -251.7% | -189.2% | -143.5% | -103.1% | -76.9% | -80.9% | -61.0% | -51.2% |
| Current Ratio | 2.64x | 3.07x | 3.67x | 4.67x | 5.79x | 5.98x | 6.51x | 9.35x |
| Quick Ratio | 2.37x | 2.83x | 3.55x | 4.57x | 5.66x | 5.67x | 6.38x | 9.21x |
| Debt to Equity | 0.04x | 0.03x | 0.03x | 0.02x | 0.02x | 0.03x | 0.02x | 0.02x |
| **Revenue Growth (YoY)** | -46.5% | +504.9% | -- | +29.5% | +41.0% | +190.5% | -107.6% | -43.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
